Pinebridge Investments L.P. lifted its holdings in Vitamin Shoppe, Inc (NYSE:VSI) by 37.5% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 49,682 shares of the specialty retailer’s stock after purchasing an additional 13,548 shares during the quarter. Pinebridge Investments L.P. owned 0.21% of Vitamin Shoppe worth $579,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. BNP Paribas Arbitrage SA grew its position in Vitamin Shoppe by 2.1% in the second quarter. BNP Paribas Arbitrage SA now owns 9,242 shares of the specialty retailer’s stock worth $108,000 after acquiring an additional 192 shares in the last quarter. Municipal Employees Retirement System of Michigan raised its position in Vitamin Shoppe by 18.1% during the second quarter. Municipal Employees Retirement System of Michigan now owns 9,410 shares of the specialty retailer’s stock valued at $110,000 after purchasing an additional 1,440 shares during the period. Mason Street Advisors LLC raised its position in Vitamin Shoppe by 7.0% during the first quarter. Mason Street Advisors LLC now owns 5,569 shares of the specialty retailer’s stock valued at $112,000 after purchasing an additional 366 shares during the period. UBS Asset Management Americas Inc. raised its position in Vitamin Shoppe by 17,041.4% during the second quarter. UBS Asset Management Americas Inc. now owns 11,999 shares of the specialty retailer’s stock valued at $140,000 after purchasing an additional 11,929 shares during the period. Finally, Arizona State Retirement System raised its position in Vitamin Shoppe by 0.8% during the second quarter. Arizona State Retirement System now owns 12,460 shares of the specialty retailer’s stock valued at $145,000 after purchasing an additional 100 shares during the period. 96.86% of the stock is owned by hedge funds and other institutional investors.

Shares of Vitamin Shoppe, Inc (NYSE VSI) opened at 5.35 on Monday. The stock has a 50 day moving average price of $6.38 and a 200 day moving average price of $12.76. The stock’s market capitalization is $124.24 million. Vitamin Shoppe, Inc has a one year low of $4.95 and a one year high of $28.41.

Vitamin Shoppe (NYSE:VSI) last posted its quarterly earnings results on Wednesday, August 9th. The specialty retailer reported $0.23 earnings per share for the quarter, missing the consensus estimate of $0.39 by ($0.16). The firm had revenue of $304.84 million during the quarter, compared to analysts’ expectations of $314.74 million. Vitamin Shoppe had a negative net margin of 11.98% and a positive return on equity of 8.33%. The business’s quarterly revenue was down 8.4% on a year-over-year basis. During the same period last year, the company earned $0.55 EPS. Equities analysts forecast that Vitamin Shoppe, Inc will post $0.79 earnings per share for the current year.

In other Vitamin Shoppe news, Director John D. Bowlin acquired 40,000 shares of the firm’s stock in a transaction that occurred on Friday, August 25th. The shares were purchased at an average cost of $5.50 per share, for a total transaction of $220,000.00. Following the completion of the acquisition, the director now owns 56,028 shares of the company’s stock, valued at approximately $308,154. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.07% of the stock is currently owned by insiders.

ILLEGAL ACTIVITY WARNING: This story was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The original version of this story can be viewed at https://www.thecerbatgem.com/2017/10/02/pinebridge-investments-l-p-boosts-stake-in-vitamin-shoppe-inc-vsi.html.

A number of equities analysts have recently commented on the company. Zacks Investment Research upgraded Vitamin Shoppe from a “strong sell” rating to a “hold” rating in a report on Tuesday, July 18th. BidaskClub lowered Vitamin Shoppe from a “hold” rating to a “sell” rating in a report on Thursday, July 27th. Morgan Stanley set a $8.00 price target on Vitamin Shoppe and gave the company a “hold” rating in a report on Thursday, August 10th. Goldman Sachs Group, Inc. (The) restated a “sell” rating and set a $6.00 price target (down previously from $13.00) on shares of Vitamin Shoppe in a report on Thursday, August 10th. Finally, Deutsche Bank AG restated a “hold” rating and issued a $7.00 price target (down from $14.00) on shares of Vitamin Shoppe in a research report on Thursday, August 10th. Four analysts have rated the stock with a sell rating and six have given a hold rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $12.43.

Vitamin Shoppe Company Profile

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Institutional Ownership by Quarter for Vitamin Shoppe (NYSE:VSI)

Receive News & Stock Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related stocks with our FREE daily email newsletter.